{"id":"W4387825383","doi":"10.1016/j.annonc.2023.09.2360","title":"1327P First-line osimertinib in patients with EGFR mutated lung cancer with uncommon mutations (OCELOT study – interim analysis)","year":2023,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency; University of British Columbia; Grand River Hospital; William Osler Health System; Ottawa Hospital; University Health Network; Health Sciences Centre; Juravinski Cancer Centre; Sunnybrook Health Science Centre; Lakeridge Health; Princess Margaret Cancer Centre; Hamilton Health Sciences; Brampton Civic Hospital; London Health Sciences Centre","funders":"","keywords":"Osimertinib; Medicine; Pemetrexed; Lung cancer; Internal medicine; Clinical endpoint; Oncology; T790M; Interim analysis; Cohort; Population; Epidermal growth factor receptor; Cancer; Chemotherapy; Clinical trial; Erlotinib; Gefitinib","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002557894,0.001129406,0.002062779,0.0003371893,0.0003543103,0.0020997,0.0007214149,0.000847093,0.003476707],"category_scores_gemma":[0.001561309,0.0006331019,0.004664764,0.000668457,0.0005317478,0.001368872,0.000737865,0.002473606,0.0009926391],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000919371,"about_ca_system_score_gemma":0.001546158,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001351927,"about_ca_topic_score_gemma":0.005794783,"domain_scores_codex":[0.9987955,0.0004007109,0.00006795329,0.0002436317,0.0001479134,0.0003442889],"domain_scores_gemma":[0.998956,0.0001672292,0.000276499,0.0002565833,0.00008999528,0.0002537052],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6099034,0.002918212,0.2104554,0.001041727,0.02801046,0.001034394,0.0001937764,0.008774114,0.009074486,0.001295984,0.0274854,0.09981264],"study_design_scores_gemma":[0.1870535,0.07464252,0.6482817,0.0004481875,0.03444661,0.002330761,0.0003743261,0.008871553,0.006252395,0.003610979,0.03338683,0.0003006651],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9787541,0.002690596,0.001121084,0.0006754697,0.0002636114,0.0002778299,0.01045024,0.00009721657,0.005669906],"genre_scores_gemma":[0.9717462,0.001004269,0.00109169,0.001102291,0.0002473096,0.0003673842,0.02037213,0.00008622019,0.003982367],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003476707,"threshold_uncertainty_score":0.01352757,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05283033630105673,"score_gpt":0.4452087737739607,"score_spread":0.392378437472904,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}